Brian G. Priestly

1.1k total citations
46 papers, 884 citations indexed

About

Brian G. Priestly is a scholar working on Oncology, Pharmacology and Pediatrics, Perinatology and Child Health. According to data from OpenAlex, Brian G. Priestly has authored 46 papers receiving a total of 884 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Oncology, 12 papers in Pharmacology and 9 papers in Pediatrics, Perinatology and Child Health. Recurrent topics in Brian G. Priestly's work include Drug Transport and Resistance Mechanisms (13 papers), Carcinogens and Genotoxicity Assessment (8 papers) and Drug-Induced Hepatotoxicity and Protection (8 papers). Brian G. Priestly is often cited by papers focused on Drug Transport and Resistance Mechanisms (13 papers), Carcinogens and Genotoxicity Assessment (8 papers) and Drug-Induced Hepatotoxicity and Protection (8 papers). Brian G. Priestly collaborates with scholars based in Australia, Canada and Sweden. Brian G. Priestly's co-authors include Gàbriel L. Plaa, Neill H. Stacey, Roger Drew, Michel G. Côté, John W. Edwards, Andrew W. Harman, Malcolm Sim, Andrew J. Harford, D. B. Frewin and Andrew Humpage and has published in prestigious journals such as Pharmacological Reviews, Annals of the New York Academy of Sciences and Journal of Pharmacology and Experimental Therapeutics.

In The Last Decade

Brian G. Priestly

44 papers receiving 844 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Brian G. Priestly Australia	16	329	318	148	121	112	46	884
Peter H. Bach United Kingdom	19	134 0.4×	284 0.9×	65 0.4×	338 2.8×	44 0.4×	70	1.1k
Kimberly Freeman United States	14	119 0.4×	168 0.5×	301 2.0×	110 0.9×	41 0.4×	19	749
Mostafa Z. Badr United States	21	125 0.4×	113 0.4×	244 1.6×	644 5.3×	128 1.1×	66	1.4k
Iván L. Csanaky United States	20	746 2.3×	359 1.1×	181 1.2×	485 4.0×	359 3.2×	38	1.6k
J. Peters United States	12	237 0.7×	137 0.4×	305 2.1×	715 5.9×	109 1.0×	19	1.4k
Y Konishi Japan	18	237 0.7×	130 0.4×	200 1.4×	556 4.6×	103 0.9×	48	1.3k
Rie Noshiro Japan	11	570 1.7×	136 0.4×	149 1.0×	262 2.2×	40 0.4×	12	1.1k
G Ugazio Italy	15	71 0.2×	258 0.8×	92 0.6×	174 1.4×	105 0.9×	63	847
William J. Brock United States	14	103 0.3×	128 0.4×	161 1.1×	127 1.0×	35 0.3×	41	671

Countries citing papers authored by Brian G. Priestly

Since Specialization

Citations

This map shows the geographic impact of Brian G. Priestly's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Brian G. Priestly with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Brian G. Priestly more than expected).

Fields of papers citing papers by Brian G. Priestly

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Brian G. Priestly. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Brian G. Priestly. The network helps show where Brian G. Priestly may publish in the future.

Co-authorship network of co-authors of Brian G. Priestly

This figure shows the co-authorship network connecting the top 25 collaborators of Brian G. Priestly. A scholar is included among the top collaborators of Brian G. Priestly based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Brian G. Priestly. Brian G. Priestly is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Anderson, Janet K., Ian T. Cousins, Jamie C. DeWitt, et al.. (2022). Grouping of PFAS for human health risk assessment: Findings from an independent panel of experts. Regulatory Toxicology and Pharmacology. 134. 105226–105226. 28 indexed citations

Glass, Deborah C., Sue D. Xiang, P.M. Dean, et al.. (2017). Immunological effects among workers who handle engineered nanoparticles. Occupational and Environmental Medicine. 74(12). 868–876. 13 indexed citations

Dong, Zhaomin, Md Mezbaul Bahar, Joytishna Jit, et al.. (2017). Issues raised by the reference doses for perfluorooctane sulfonate and perfluorooctanoic acid. Environment International. 105. 86–94. 46 indexed citations

Stebbing, Margaret Susanne, et al.. (2008). Scientific Program: Selected Presentations - Cancer Clusters In the News: Risk Perception, Risk Communication and the Media. 15(2). 27.

Harford, Andrew J., John W. Edwards, Brian G. Priestly, & Paul Wright. (2007). Current OHS best practices for the Australian nanotechnology industry: A position paper by the NanoSafe Australia Network. RMIT Research Repository (RMIT University Library). 23(4). 315–331. 8 indexed citations

Priestly, Brian G., John W. Edwards, Andrew J. Harford, & Paul Wright. (2007). Current OHS best practices for the Australian nanotechnology industry. Flinders Academic Commons (Flinders University). 2 indexed citations

Aroni, Rosalie, et al.. (2006). Affective Evaluation, Trust, Perceived Risk and Acceptability of New Technology - the Case of Nanotechnology in Australia. 13(3). 95. 4 indexed citations

Priestly, Brian G., M. R. Moore, B. N. Noller, & J. C. Ng. (2004). Human Health Risk Assessment. Queensland's institutional digital repository (The University of Queensland). 107–172. 1 indexed citations

Priestly, Brian G., et al.. (2000). Clofibrate pretreatment in mice confers resistance against hepatic lipid peroxidation. Journal of Biochemical and Molecular Toxicology. 14(6). 335–345. 12 indexed citations

10.

Priestly, Brian G., et al.. (1998). Carcinogen risk assessment. Can we harmonise?. Toxicology Letters. 102-103. 241–246. 5 indexed citations

11.

Edwards, John W. & Brian G. Priestly. (1994). Effect of occupational exposure to aldrin on urinary d-glucaric acid, plasma dieldrin, and lymphocyte sister chromatid exchange. International Archives of Occupational and Environmental Health. 66(4). 229–234. 5 indexed citations

12.

Edwards, John W. & Brian G. Priestly. (1993). Sister chromatid exchanges in lymphocytes of petroleum retailers.. Occupational and Environmental Medicine. 50(2). 149–154. 10 indexed citations

13.

Bruschi, Sam A. & Brian G. Priestly. (1990). Implication of alterations in intracellular calcium ion homoeostasis in the advent of paracetamol-induced cytotoxicity in primary mouse hepatocyte monolayer cultures. Toxicology in Vitro. 4(6). 743–749. 8 indexed citations

14.

Drew, Roger & Brian G. Priestly. (1978). Failure of hypoactive hypertrophic smooth endoplasmic reticulum to produce cholestasis in rats. Toxicology and Applied Pharmacology. 45(1). 191–199. 5 indexed citations

15.

Harman, Andrew W., Brian G. Priestly, & D. B. Frewin. (1977). A COMPARATIVE STUDY OF ANTIPYRINE PHARMACOKINETICS IN SALIVA AND PLASMA USING A COLOURIMETRIC METHOD OF ANTIPYRINE ANALYSIS. Clinical and Experimental Pharmacology and Physiology. 4(6). 593–596. 2 indexed citations

16.

Drew, Roger & Brian G. Priestly. (1976). Hexobarbital sleeping time and drug metabolism in rats with ligated bile ducts—A lack of correlation. Biochemical Pharmacology. 25(14). 1659–1663. 13 indexed citations

17.

Coates, Peter E., et al.. (1972). Pharmacokinetic models for the biliary excretion of amaranth in the rat. Life Sciences. 11(4). 197–208. 6 indexed citations

18.

Priestly, Brian G. & Gàbriel L. Plaa. (1970). SULFOBROMOPHTHALEIN METABOLISM AND EXCRETION IN RATS WITH IODOMETHANE-INDUCED DEPLETION OF HEPATIC GLUTATHIONE. Journal of Pharmacology and Experimental Therapeutics. 175(1). 235–235. 1 indexed citations

19.

Priestly, Brian G. & Gàbriel L. Plaa. (1969). Effects of Benziodarone on the Metabolism and Biliary Excretion of Sulfobromophthalein and Related Dyes. Experimental Biology and Medicine. 132(3). 881–885. 11 indexed citations

20.

Priestly, Brian G., et al.. (1966). Protein binding and the excretion of some azo dyes in rat bile. Journal of Pharmacy and Pharmacology. 18(1). 41–45. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact